BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29992699)

  • 1. Pharmacogenetics of inhaled long-acting beta2-agonists in asthma: A systematic review.
    Slob EMA; Vijverberg SJH; Palmer CNA; Zazuli Z; Farzan N; Oliveri NMB; Pijnenburg MW; Koppelman GH; Maitland-van der Zee AH
    Pediatr Allergy Immunol; 2018 Nov; 29(7):705-714. PubMed ID: 29992699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood asthma exacerbations and the Arg16 β2-receptor polymorphism: A meta-analysis stratified by treatment.
    Turner S; Francis B; Vijverberg S; Pino-Yanes M; Maitland-van der Zee AH; Basu K; Bignell L; Mukhopadhyay S; Tavendale R; Palmer C; Hawcutt D; Pirmohamed M; Burchard EG; Lipworth B;
    J Allergy Clin Immunol; 2016 Jul; 138(1):107-113.e5. PubMed ID: 26774659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study.
    Ortega VE; Hawkins GA; Moore WC; Hastie AT; Ampleford EJ; Busse WW; Castro M; Chardon D; Erzurum SC; Israel E; Montealegre F; Wenzel SE; Peters SP; Meyers DA; Bleecker ER
    Lancet Respir Med; 2014 Mar; 2(3):204-13. PubMed ID: 24621682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of β2-adrenergic receptor gene (ADRB2) 3' untranslated region polymorphisms on inhaled corticosteroid/long-acting β2-adrenergic agonist response.
    Ambrose HJ; Lawrance RM; Cresswell CJ; Goldman M; Meyers DA; Bleecker ER
    Respir Res; 2012 May; 13(1):37. PubMed ID: 22559839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
    Ni CM; Greenstone IR; Ducharme FM
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting β2-agonist step-off in patients with controlled asthma.
    Brozek JL; Kraft M; Krishnan JA; Cloutier MM; Lazarus SC; Li JT; Santesso N; Strunk RC; Casale TB
    Arch Intern Med; 2012 Oct; 172(18):1365-75. PubMed ID: 22928176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined pharmacogenetic effect of ADCY9 and ADRB2 gene polymorphisms on the bronchodilator response to inhaled combination therapy.
    Kim SH; Ye YM; Lee HY; Sin HJ; Park HS
    J Clin Pharm Ther; 2011 Jun; 36(3):399-405. PubMed ID: 21545619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADRB2 haplotypes and asthma exacerbations in children and young adults: An individual participant data meta-analysis.
    Karimi L; Vijverberg SJ; Engelkes M; Hernandez-Pacheco N; Farzan N; Soares P; Pino-Yanes M; Jorgensen AL; Eng C; Mukhopadhyay S; Schieck M; Kabesch M; Burchard EG; Chew FT; Sio YY; Potočnik U; Gorenjak M; Hawcutt DB; Palmer CN; Turner S; Janssens HM; Maitland-van der Zee AH; Verhamme KMC;
    Clin Exp Allergy; 2021 Sep; 51(9):1157-1171. PubMed ID: 34128573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arg16 ADRB2 genotype increases the risk of asthma exacerbation in children with a reported use of long-acting β2-agonists: results of the PACMAN cohort.
    Zuurhout MJ; Vijverberg SJ; Raaijmakers JA; Koenderman L; Postma DS; Koppelman GH; Maitland-van der Zee AH
    Pharmacogenomics; 2013 Dec; 14(16):1965-71. PubMed ID: 24279851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of
    Scaparrotta A; Franzago M; Marcovecchio ML; Di Pillo S; Chiarelli F; Mohn A; Stuppia L
    J Aerosol Med Pulm Drug Deliv; 2019 Jun; 32(3):164-173. PubMed ID: 30855197
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment response heterogeneity in asthma: the role of genetic variation.
    Vijverberg SJH; Farzan N; Slob EMA; Neerincx AH; Maitland-van der Zee AH
    Expert Rev Respir Med; 2018 Jan; 12(1):55-65. PubMed ID: 29115880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ram FS; Cates CJ; Ducharme FM
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of beta2 adrenergic receptor agonists in asthma management.
    Ortega VE
    Clin Genet; 2014 Jul; 86(1):12-20. PubMed ID: 24641588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.
    Bleecker ER; Postma DS; Lawrance RM; Meyers DA; Ambrose HJ; Goldman M
    Lancet; 2007 Dec; 370(9605):2118-25. PubMed ID: 18156033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of ADRB2 (Arg16Gly) Gene Variant with Susceptibility, Pharmacogenetic Response and Disease Severity in South Indian Asthmatics.
    Bandaru S; Akka J; Marri VK; Alvala M; Ponnala D; Mundluru HP
    Inflammation; 2015 Dec; 38(6):2146-55. PubMed ID: 26071206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics of long-acting β2-agonists.
    Blake K; Lima J
    Expert Opin Drug Metab Toxicol; 2015; 11(11):1733-51. PubMed ID: 26235677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of beta2-adrenergic receptor gene in serbian asthmatic adults: effects on response to Beta-agonists.
    Petrovic-Stanojevic N; Topic A; Nikolic A; Stankovic M; Dopudja-Pantic V; Milenkovic B; Radojkovic D
    Mol Diagn Ther; 2014 Dec; 18(6):639-46. PubMed ID: 25074500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine.
    Ortega VE; Meyers DA
    J Allergy Clin Immunol; 2014 Jan; 133(1):16-26. PubMed ID: 24369795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.